BeiGene, Ltd. Files Q1 2025 10-Q
Ticker: BEIGF · Form: 10-Q · Filed: May 7, 2025 · CIK: 1651308
| Field | Detail |
|---|---|
| Company | Beigene, LTD. (BEIGF) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals, SEC filing
Related Tickers: BGNE
TL;DR
BeiGene's Q1 2025 10-Q is in: financials and operations updated.
AI Summary
BeiGene, Ltd. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment performances are presented, reflecting the company's ongoing activities in the pharmaceutical sector.
Why It Matters
This filing provides investors and stakeholders with the latest financial health and operational status of BeiGene, Ltd., crucial for understanding its market position and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, BeiGene faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-07 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- BeiGene, Ltd. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250507 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 7, 2025.
What is the Standard Industrial Classification (SIC) code for BeiGene, Ltd.?
The SIC code for BeiGene, Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
What fiscal year end does BeiGene, Ltd. observe?
BeiGene, Ltd. observes a fiscal year end of December 31.
What is the SEC file number for BeiGene, Ltd.?
The SEC file number for BeiGene, Ltd. is 001-37686.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding BeiGene, Ltd. (BEIGF).